The 6th Global Forum on TB Vaccines will take place from 22-24 February 2022 in Toulouse, France, under the high patronage of Mr. Emmanuel Macron, President of the French Republic, and under the patronage of Mr. Olivier Véran, Minister for Solidarity and Health. The theme of the 6th Global Forum is "New horizons for TB vaccines".
The 6th Global Forum on TB Vaccines is currently planned to be a hybrid conference, with options for in-person and online participation. The Organizing Partners are carefully monitoring the COVID-19 pandemic and its potential impact on the in-person component of the 6th Global Forum. Information will be posted as it becomes available.
Abstracts and Registrations The Global Forum Organizers and Organizing Committee invite abstracts for potential oral or poster (on-site or virtual) presentation at the 6th Global Forum on TB Vaccines. The abstract submission platform will be open from 1 September-15 October 2021. Learn more.
Registration for the 6th Global Forum will open in October 2021.
The Global Forum on TB Vaccines is the world’s largest gathering of stakeholders striving to develop new vaccines to prevent TB. It provides an important and unique opportunity to review the state of the field, share the latest research findings, and identify new and innovative approaches to TB vaccine R&D, with the end goal of developing and deploying new TB vaccines as quickly as possible.
For information about the 6th Global Forum on TB Vaccines, visit https://toulouse.tbvaccinesforum.org/
Submissions Open for Late-Breaker Sessions on TB, COVID-19 and Lung Health
The 52nd Union World Conference on Lung Health is pleased to announce that submissions for Late-Breaker Sessions are open from 15 July-12 August 2021. Submit now.
In keeping with the spirit of a late-breaker session, we ask that only new, innovative and significant findings of broad interest that have occurred after 12 May, or for which information has just become available, be submitted for the late-breaker sessions.
The following three late-breaker sessions are slated for the Conference that will take place from 19-22 October 2021:
THE UNION LATE-BREAKER SESSION ON COVID-19
All aspects of SARS-CoV-2 and Covid-19-related lung health are welcomed for presentation during the late-breaker session, from basic science in immunology and vaccines, clinical trials for vaccines or therapeutics, to operational research in adults and children.
This session will consist of up to seven pre-recorded oral presentations of 8 minutes each, followed by live Q&A with the online audience.
THE UNION/CDC LATE-BREAKER SESSION ON TB
The 52nd Union World Conference on Lung Health and the United States Centers for Disease Control and Prevention (CDC) are pleased to announce a late-breaker session related to tuberculosis (TB).
This late-breaker session includes all aspects of TB prevention, diagnosis, and treatment research (including basic and clinical science, epidemiology, social, behavioural, and health care delivery). Given the global COVID-19 pandemic, we will also consider select presentations that explore the intersection of COVID-19 and TB prevention and programmatic implementation. It will consist of 7 pre-recorded oral presentations of 8 minutes each and live Q&A at the end of the session. The session is scheduled on 22 October 2021.
THE UNION STUDENT LATE-BREAKER SESSION ON LUNG HEALTH
The 52nd Union World Conference on Lung Health is pleased to announce the Union student late-breaker session focusing on lung health and sponsored by the Research Institute of Tuberculosis of the Japan Anti-Tuberculosis Association (RIT/JATA).
All aspects of lung health are welcomed for presentation during the late-breaker session, from basic science in immunology and vaccines, to operational research in tuberculosis (TB), Chronic Obstructive Pulmonary Disease (COPD), pneumonia, and other lung health issues in adults and children. This session will consist of up to seven pre-recorded oral presentations of 8 minutes each, followed by live Q&A with online audience.
Individuals submitting an abstract must be currently enrolled as a student in a university programme at undergraduate, graduate, or doctoral level either full- or part-time.
DETAILS
All abstracts must follow the abstract submission guidelines
For more information and details on sponsorship for late-breaker sessions: https://theunion.org/late-breaker-sessions
For any further queries, email scientific@theunion.org
Submit now!
The 52nd Union World Conference on Lung Health is pleased to announce that submissions for Late-Breaker Sessions are open from 15 July-12 August 2021. Submit now!
In keeping with the spirit of a late-breaker session, we ask that only new, innovative and significant findings of broad interest that have occurred after 12 May, or for which information has just become available, be submitted for the late-breaker sessions.
The following three late-breaker sessions are slated for the Conference that will take place from 19-22 October 2021:
THE UNION LATE-BREAKER SESSION ON COVID-19
All aspects of SARS-CoV-2 and Covid-19-related lung health are welcomed for presentation during the late-breaker session, from basic science in immunology and vaccines, clinical trials for vaccines or therapeutics, to operational research in adults and children.
This session will consist of up to seven pre-recorded oral presentations of 8 minutes each, followed by live Q&A with the online audience.
THE UNION/CDC LATE-BREAKER SESSION ON TB
The 52nd Union World Conference on Lung Health and the United States Centers for Disease Control and Prevention (CDC) are pleased to announce a late-breaker session related to tuberculosis (TB).
This late-breaker session includes all aspects of TB prevention, diagnosis, and treatment research (including basic and clinical science, epidemiology, social, behavioural, and health care delivery). Given the global COVID-19 pandemic, we will also consider select presentations that explore the intersection of COVID-19 and TB prevention and programmatic implementation. It will consist of 7 pre-recorded oral presentations of 8 minutes each and live Q&A at the end of the session. The session is scheduled on 22 October 2021.
THE UNION STUDENT LATE-BREAKER SESSION ON LUNG HEALTH
The 52nd Union World Conference on Lung Health is pleased to announce the Union student late-breaker session focusing on lung health and sponsored by the Research Institute of Tuberculosis of the Japan Anti-Tuberculosis Association (RIT/JATA).
All aspects of lung health are welcomed for presentation during the late-breaker session, from basic science in immunology and vaccines, to operational research in tuberculosis (TB), Chronic Obstructive Pulmonary Disease (COPD), pneumonia, and other lung health issues in adults and children. This session will consist of up to seven pre-recorded oral presentations of 8 minutes each, followed by live Q&A with online audience.
Individuals submitting an abstract must be currently enrolled as a student in a university programme at undergraduate, graduate, or doctoral level either full- or part-time.
DETAILS
All abstracts must follow the abstract submission guidelines
For more information and details on sponsorship for late-breaker sessions: https://theunion.org/late-breaker-sessions
For any further queries, email scientific@theunion.org
This project was coordinated by the ICGEB and implemented in partnership with reference testing laboratories in Africa. ICGEB Member States, Cameroon, Ethiopia, Kenya, and Nigeria, have taken part in a pilot study to assess the efficacy of a novel diagnostic tool in diverse settings. Dr Joseph Fokam (TMA2015CDF1027) was the local PI in Cameroon.
This pilot study, performed during the period September 2020-May 2021, contributed to the accuracy in detecting SARS-CoV-2 in resource-limited settings. It evaluated the diagnostic performance of RT-LAMP in terms of intrinsic (sensitivity, specificity) and extrinsic (positive and negative predictive values) characteristics according to SARS-CoV-2 viral load estimates provided by the conventional RT-qPCR in four LMICs of Sub-Saharan Africa. Results from the study show that RT-LAMP represents a formidable alternative to RT-qPCR. New England BioLabs freely contributed its LAMP technology to the study, and the Bill & Melinda Gates Foundation funded the project (INV – 022816).
To learn more about this exciting project visit https://www.youtube.com/watch?v=F-xSlulkN-4
Read more